|
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2025-08-28
Est. completion2030-06-30
Eligibility
Age18 Years – 100 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07207564
Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Eligibility
Age: 18 Years – 100 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Female patients, ages 18 to 100 years * Had a benign breast biopsy at Mayo Clinic between 2002-2022 Exclusion Criteria: * All male patients * Prior or concomitant diagnosis of BC * Diagnosis of BC within six months of benign breast disease * Denial of research authorization * Concurrent or post-biopsy bilateral prophylactic mastectomy
Conditions3
Breast CancerBreast CarcinomaCancer
Locations2 sites
Florida
1 siteMayo Clinic in Florida
Jacksonville, Florida, 32224-9980
Minnesota
1 siteMayo Clinic in Rochester
Rochester, Minnesota, 55905
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMayo Clinic
Started2025-08-28
Est. completion2030-06-30
Eligibility
Age18 Years – 100 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07207564